A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

The bullish sentiment is expected to sustain with the VIX reaching a one-month low. Below are some trading ideas for the near ...

Moneycontrol collated a list of 9 budget-sensitive stocks from experts that can provide better returns in the short term.